{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:05:43Z","timestamp":1790283943310,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":229,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 AG077310"],"award-info":[{"award-number":["R21 AG077310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.jp","jvsvs.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JVS-Vascular Science"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jvssci.2026.100441","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:44:33Z","timestamp":1787615073000},"page":"100441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Poor glycemic control is independently associated with fibrinolysis shutdown in patients with peripheral artery disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Swechha","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aseman Bagheri","family":"Sheshdeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shezan","family":"Fouzdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5363-1971","authenticated-orcid":false,"given":"Radha","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2354-7848","authenticated-orcid":false,"given":"Prajakta","family":"Lokhande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanaya","family":"Vimadalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3349-4233","authenticated-orcid":false,"given":"Anahita","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvssci.2026.100441_bib1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jvssci.2026.100441_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.recesp.2017.12.015","article-title":"2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS)","volume":"71","author":"Aboyans","year":"2018","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"Suppl S","key":"10.1016\/j.jvssci.2026.100441_bib3","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the management of peripheral arterial disease (TASC II)","volume":"45","author":"Norgren","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvssci.2026.100441_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","article-title":"Fibrinolysis and the control of blood coagulation","volume":"29","author":"Chapin","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.jvssci.2026.100441_bib5","first-page":"521","article-title":"Management of life-threatening hemorrhage","volume":"22","author":"Gonzalez","year":"2016","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jvssci.2026.100441_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jamcollsurg.2016.01.006","article-title":"Acute fibrinolysis shutdown after injury occurs frequently and increases mortality: a multicenter evaluation of 2,540 severely injured patients","volume":"222","author":"Moore","year":"2016","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jvssci.2026.100441_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jamcollsurg.2016.12.018","article-title":"Persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients","volume":"224","author":"Meizoso","year":"2017","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jvssci.2026.100441_bib8","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1161\/01.ATV.0000242905.41404.68","article-title":"PAI-1 and the metabolic syndrome: links, causes, and consequences","volume":"26","author":"Alessi","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvssci.2026.100441_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2796.2007.01824.x","article-title":"Diabetes mellitus as a prothrombotic condition","volume":"262","author":"Grant","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.jvssci.2026.100441_bib10","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00125-005-1742-2","article-title":"The influence of type 2 diabetes on fibrin structure and function","volume":"48","author":"Dunn","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.jvssci.2026.100441_bib11","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1046\/j.1538-7836.2003.00279.x","article-title":"Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk","volume":"1","author":"Juhan-Vague","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"Suppl 1","key":"10.1016\/j.jvssci.2026.100441_bib12","first-page":"S20","article-title":"Standards of medical care in Diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jvssci.2026.100441_bib13","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1056-8727(00)00132-X","article-title":"Diabetes mellitus: a hypercoagulable state","volume":"15","author":"Carr","year":"2001","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.jvssci.2026.100441_bib14","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/TA.0b013e318292cc54","article-title":"Tranexamic acid in trauma: how should we use it?","volume":"74","author":"Napolitano","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.jvssci.2026.100441_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/jth.12078","article-title":"The incidence and magnitude of fibrinolytic activation in trauma patients","volume":"11","author":"Raza","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jvssci.2026.100441_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2026.03.293","article-title":"Association of insulin therapy with clot strength in diabetic patients with peripheral artery disease","author":"Fouzdar","year":"2026","journal-title":"J Vasc Surg Vasc Sci"},{"key":"10.1016\/j.jvssci.2026.100441_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvs.2026.07.013","article-title":"Serotonergic antidepressant initiation associated with increased platelet inhibition variability after lower-extremity revascularization","author":"Bansal","year":"2026","journal-title":"J Vasc Surg"}],"container-title":["JVS-Vascular Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666350326000349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666350326000349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:55:48Z","timestamp":1790283348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666350326000349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":17,"alternative-id":["S2666350326000349"],"URL":"https:\/\/doi.org\/10.1016\/j.jvssci.2026.100441","relation":{},"ISSN":["2666-3503"],"issn-type":[{"value":"2666-3503","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poor glycemic control is independently associated with fibrinolysis shutdown in patients with peripheral artery disease","name":"articletitle","label":"Article Title"},{"value":"JVS-Vascular Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvssci.2026.100441","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.","name":"copyright","label":"Copyright"}],"article-number":"100441"}}